These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19911951)

  • 41. [Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs].
    Vázquez-Cortés S; Vázquez-Fuertes L; Rodríguez-Alvarez M; Reig Rincón de Arellano I; Martínez-Cócera C
    An Med Interna; 2008 Apr; 25(4):163-7. PubMed ID: 18604331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib.
    Quiñones OG; Mata dos Santos HA; Kibwila DM; Leitão A; dos Santos Pyrrho A; Pádula Md; Rosas EC; Lara MG; Pierre MB
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1180-9. PubMed ID: 23826859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analgesic comparison of meloxicam or ketoprofen for orthopedic surgery in dogs.
    Deneuche AJ; Dufayet C; Goby L; Fayolle P; Desbois C
    Vet Surg; 2004; 33(6):650-60. PubMed ID: 15659022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of microemulsion system for transdermal delivery of meloxicam.
    Yuan Y; Li SM; Mo FK; Zhong DF
    Int J Pharm; 2006 Sep; 321(1-2):117-23. PubMed ID: 16876972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of Curcumin loaded chitosan polymer based nanoemulsion gel: In vitro, ex vivo evaluation and in vivo wound healing studies.
    Thomas L; Zakir F; Mirza MA; Anwer MK; Ahmad FJ; Iqbal Z
    Int J Biol Macromol; 2017 Aug; 101():569-579. PubMed ID: 28322948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation and cytotoxicity evaluation of new self-emulsifying multiple W/O/W nanoemulsions.
    Sigward E; Mignet N; Rat P; Dutot M; Muhamed S; Guigner JM; Scherman D; Brossard D; Crauste-Manciet S
    Int J Nanomedicine; 2013; 8():611-25. PubMed ID: 23403891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NANOEMULSION WITH CLOTRIMAZOLE - DESIGN AND OPTIMALIZATION OF MEAN DROPLET SIZE USING MICROFLUIDIZATION TECHNIQUE.
    Sosnowska K; Szymanska E; Winnicka K
    Acta Pol Pharm; 2017 Mar; 74(2):519-526. PubMed ID: 29624257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pomegranate seed oil nanoemulsions improve the photostability and in vivo antinociceptive effect of a non-steroidal anti-inflammatory drug.
    Ferreira LM; Sari MHM; Cervi VF; Gehrcke M; Barbieri AV; Zborowski VA; Beck RCR; Nogueira CW; Cruz L
    Colloids Surf B Biointerfaces; 2016 Aug; 144():214-221. PubMed ID: 27088191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion.
    Subramanian N; Ghosal SK; Moulik SP
    Drug Dev Ind Pharm; 2005 May; 31(4-5):405-16. PubMed ID: 16093206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib.
    McDonald BF; Coulter IS; Marison IW
    Pharm Dev Technol; 2015 Mar; 20(2):211-8. PubMed ID: 24283499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability.
    Thakkar HP; Khunt A; Dhande RD; Patel AA
    J Microencapsul; 2015; 32(6):559-69. PubMed ID: 26333939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-excipient compatibility assessment of solid formulations containing meloxicam.
    da Silveira LM; Fiorot AB; Xavier TP; Yoshida MI; de Oliveira MA
    Eur J Pharm Sci; 2018 Jan; 112():146-151. PubMed ID: 29174987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam.
    Bravo González RC; Huwyler J; Boess F; Walter I; Bittner B
    Biopharm Drug Dispos; 2004 Jan; 25(1):37-49. PubMed ID: 14716751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent.
    Harirforoosh S; Aghazadeh-Habashi A; Jamali F
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):917-24. PubMed ID: 17002668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
    Ha ES; Ok J; Noh J; Jeong HY; Choo GH; Jung YS; Baek IH; Kim JS; Cho W; Hwang SJ; Kim MS
    Int J Biol Macromol; 2015 Jan; 72():1473-8. PubMed ID: 25451745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis.
    Srivastava M; Kohli K; Ali M
    Drug Deliv; 2016; 23(1):154-66. PubMed ID: 24786482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The application of artificial neural networks in the prediction of microemulsion phase boundaries in PEG-8 caprylic/capric glycerides based systems.
    Djekic L; Ibric S; Primorac M
    Int J Pharm; 2008 Sep; 361(1-2):41-6. PubMed ID: 18571348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of crystallization and growth of celecoxib nanoparticles formed from volatile microemulsions.
    Margulis-Goshen K; Weitman M; Major DT; Magdassi S
    J Pharm Sci; 2011 Oct; 100(10):4390-400. PubMed ID: 21630277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cosolvent solubilization and formulation of an aqueous injection of ketoprofen.
    Singhai AK; Jain S; Jain NK
    Pharmazie; 1996 Oct; 51(10):737-40. PubMed ID: 8941941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.